Skip to main content
Innoviva, Inc. logo

Innoviva, Inc. — Investor Relations & Filings

Ticker · INVA ISIN · US45781M1018 LEI · 549300ACOX4QTBES6535 US Financial and insurance activities
Open in API
Filings indexed 1,226 across all filing types
Latest filing 2017-03-20 Proxy Solicitation & In…
Country US United States of America
Listing US INVA

About Innoviva, Inc.

https://www.inva.com/

Innoviva, Inc. is a diversified holding company that manages a portfolio of royalty-generating assets and operates a commercial-stage biopharmaceutical platform. The company's core royalty business is centered on respiratory therapies, providing a stable cash flow. Through its subsidiary, Innoviva Specialty Therapeutics, it focuses on developing and commercializing innovative treatments for patients in critical care and with infectious diseases. Innoviva's strategy involves leveraging its financial assets to invest in healthcare opportunities with high unmet medical needs, aiming to advance differentiated therapies and build a diverse portfolio of healthcare assets.

Recent filings

Filing Released Lang Actions
DFAN14A
Proxy Solicitation & Information Statement
2017-03-20 English
PRRN14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'SCHEDULE 14A' and is identified as a 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934.' It is a preliminary proxy statement related to the 2017 Annual Meeting of Stockholders of Innoviva, Inc. The content includes proposals for election of directors, advisory vote on executive compensation, and repeal of new bylaws, which are typical contents of a proxy statement. The document is not an annual report, earnings release, or any other financial report but rather a solicitation of shareholder votes and information related to the annual meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is substantial (15,000 characters), indicating it is the statement itself, not just an announcement of it. Confidence is high due to clear identification and typical content of a proxy statement.
2017-03-20 English
Regulatory Filings 2017
Regulatory Filings
2017-03-17 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement or solicitation material related to shareholder voting matters. It discusses the nomination of board members, shareholder dialogue, and references the upcoming 2017 Annual Meeting and proxy materials. It explicitly states it is soliciting material under §240.14a-12 and mentions the filing of a preliminary proxy statement and forthcoming definitive proxy statement. The content focuses on proxy solicitation and shareholder voting information rather than the actual proxy statement or annual report itself. Therefore, this document is best classified as Proxy Solicitation & Information Statement (PSI). The document length (6339 characters) and content confirm it is not a brief announcement or a full annual report but detailed solicitation material.
2017-03-13 English
PREC14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'PREC14A' and is identified as a 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934.' It is a solicitation of proxies for the 2017 Annual Meeting of Stockholders of Innoviva, Inc. The content includes proposals for election of directors, advisory vote on executive compensation, and repeal of new bylaws, which are typical contents of a proxy statement. It is not an annual report, earnings release, or other financial report. The document is a preliminary proxy statement, which is a solicitation material sent to shareholders to provide information and request votes for meetings. Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI). The document length is 15,000 characters, indicating it is a full filing, not just an announcement or certification.
2017-03-13 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'SCHEDULE 14A' and is identified as a 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934.' It includes solicitation material and detailed corporate presentation content, including forward-looking statements, financial highlights, capital return plans, and market share data. Proxy statements (Schedule 14A) are materials sent to shareholders to provide information and request votes for meetings. The presence of solicitation material and the SEC form designation DEFA14A confirms this is a proxy solicitation document, not an annual report, earnings release, or other financial report. Therefore, the document fits the category of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the actual proxy statement material, not just an announcement or certification.
2017-03-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.